Predictores de la función renal en una cohorte de adultos mexicanos / Predictors of kidney function in a cohort of Mexican adults

Resumen: Objetivo: Examinar prospectivamente los predictores de alteraciones subclínicas de la función renal en adultos sin diagnóstico previo de enfermedad renal crónica. Material y métodos: Se analizaron datos de una cohorte de adultos mexicanos (n=757). La función renal (2010) se midió mediante la tasa de filtración glomerular estimada (TFGE-Cr), creatinina y ácido úrico séricos. Los predictores (2004) se identificaron con modelos de regresión lineal y logística. Resultados: Se clasificó 33% con TFGE-Cr disminuida. La TFGE-Cr fue menor en hombres, en >40 años y en usuarios de antihipertensivos; y fue mayor en aquellos con consumo proteico alto. Los predictores de la creatinina fueron similares a los de la TFGE-Cr. El ácido úrico disminuyó en participantes hombres, con obesidad, hipertensión e hipercolesterolemia. Conclusión. Los biomarcadores séricos convencionales son útiles para identificar alteraciones subclínicas de la función renal. Algunos predictores de la función renal son potencialmente modificables, por tanto susceptibles de intervención.

Abstract: Objectives: Our aim was to examine prospectively predictors of subclinical renal alterations among adults without chronic kidney disease. Materials and methods: We analyzed data from a cohort of Mexican adults (n=757). Kidney function (2010) was assessed with the estimated glomerular filtration rate (eGFR-Cr), serum creatinine and uric acid. Predictors of each kidney function marker (2004) were identified with linear and logistic regression models. Results: 33% had an eGFR-Cr <90 ml/min/1.73 m2. eGFR-Cr was lower among men, those >40 years old and users of antihypertensive medication; and higher among those with a high protein intake. Serum creatinine predictors were similar to those observed for eGFR-Cr. Uric acid decreased in men, among those with obesity, hypertension and high cholesterol. Conclusion: Conventional kidney function biomarkers are useful to identify subclinical alterations. Some predictors of kidney function are potentially modifiable, therefore susceptible for intervention among high-risk groups.

Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention

ABSTRACT Phyllanthus niruri (P.niruri) or stone breaker is a plant commonly used to reduce stone risk, however, clinical studies on this issue are lacking. Objective: To prospectively evaluate the effect of P. niruri on the urinary metabolic parameters of patients with urinary lithiasis. Materials and Methods: We studied 56 patients with kidney stones <10mm. Clinical, metabolic, and ultrasonography assessment was conducted before (baseline) the use of P. niruri infusion for 12-weeks (P. niruri) and after a 12-week (wash out) Statistical analysis included ANOVA for repeated measures and Tukey's/McNemar's test for categorical variables. Significance was set at 5%. Results: Mean age was 44±9.2 and BMI was 27.2±4.4kg/m2. Thirty-six patients (64%) were women. There were no significant changes in all periods for anthropometric and several serum measurements, including total blood count, creatinine, uric acid, sodium, potassium, calcium, urine volume and pH; a significant increase in urinary potassium from 50.5±20.4 to 56.2±21.8 mg/24-hour (p=0.017); magnesium/creatinine ratio 58±22.5 to 69.1±28.6mg/gCr24-hour (p=0.013) and potassium/creatinine ratio 39.3±15.1 to 51.3±34.7mg/gCr24-hour (p=0.008) from baseline to wash out. The kidney stones decreased from 3.2±2 to 2.0±2per patient (p<0.001). In hyperoxaluria patients, urinary oxalate reduced from 59.0±11.7 to 28.8±16.0mg/24-hour (p=0.0002), and in hyperuricosuria there was a decrease in urinary uric acid from 0.77±0.22 to 0.54±0.07mg/24-hour (p=0.0057). Conclusions: P.niruri intake is safe and does not cause significant adverse effects on serum metabolic parameters. It increases urinary excretion of magnesium and potassium caused a significant decrease in urinary oxalate and uric acid in patients with hyperoxaluria and hyperuricosuria. The consumption of P.niruri contributed to the elimination of urinary calculi.

Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers / Influência do estado nutricional e dos parâmetros laboratoriais e dietéticos sobre a excreção urinária ácida em pacientes portadores de litíase cálcica

ABSTRACT Introduction: Obesity and Metabolic Syndrome (MS) are associated with low urinary pH and represent risk factors for nephrolithiasis, especially composed by uric acid. Acidogenic diets may also contribute to a reduction of urinary pH. Propensity for calcium oxalate precipitation has been shown to be higher with increasing features of the MS. Objective: A retrospective evaluation of anthropometric and body composition parameters, MS criteria and the dietary patterns of overweight and obese calcium stone formers and their impact upon urinary pH and other lithogenic parameters was performed. Methods: Data regarding anthropometry, body composition, serum and urinary parameters and 3-days dietary records were obtained from medical records of 102(34M/68F) calcium stone formers. Results: A negative correlation was found between urinary pH, waist circumference and serum uric acid levels (males). The endogenous production of organic acids (OA) was positively correlated with triglycerides levels and number of features of MS (males), and with glucose, uric acid and triglycerides serum levels, and number of features of MS (females). No significant correlations were detected between Net Acid Excretion (NAE) or Potential Renal Acid Load of the diet with any of the assessed parameters. A multivariate analysis showed a negative association between OA and urinary pH. Conclusion: The endogenous production of OA and not an acidogenic diet were found to be independently predictive factors for lower urinary pH levels in calcium stone formers. Hypercalciuric and/or hyperuricosuric patients presented higher OA levels and lower levels of urinary pH.

RESUMO Introdução: A obesidade e a Síndrome Metabólica (SM) se associam a pH urinário ácido e representam fatores de risco para litíase renal, especialmente a úrica. Dietas acidogênicas também podem contribuir para a redução do pH urinário. Já foi demonstrado maior risco de precipitação de oxalato de cálcio em proporção aos critérios de SM. Objetivo: Avaliar retrospectivamente o impacto de parâmetros antropométricos, composição corporal, critérios de SM e padrão alimentar sobre o pH urinário e outros parâmetros litogênicos em pacientes com sobrepeso e obesos com litíase cálcica. Métodos: Foram coletados dados de antropometria, composição corporal, exames séricos e urinários, e registros alimentares (3 dias) de 102 (34M/68F) pacientes com litíase cálcica. Resultados: O pH urinário se correlacionou negativamente com a circunferência da cintura e ácido úrico sérico (homens). A produção endógena de ácidos orgânicos (AO) se correlacionou positivamente com os triglicérides séricos e o número de critérios de SM (homens), e com glicemia, ácido úrico, triglicérides e número de critérios para SM (mulheres). Não se observaram correlações significantes entre a excreção renal líquida de ácidos (NAE) e o potencial de carga ácida renal (PRAL) da dieta com nenhum dos parâmetros avaliados. Na análise de regressão multivariada, os AO apresentaram associação negativa significante com o pH urinário. Conclusão: A produção endógena de AO, e não um padrão de dieta acidogênica, foi o fator determinante independente para menores níveis de pH urinário em pacientes com litíase cálcica. Pacientes com hipercalciúria e/ou hiperuricosúria apresentaram maiores valores de AO e menores de pH urinário.

Metabolic investigation in patients with nephrolithiasis / Investigação metabólica em pacientes com nefrolitíase

ABSTRACT: Objective: To evaluate the prevalence of metabolic disorders associated with nephrolithiasis in a female population. Methods: A retrospective study on 1,737 patients with evidence of recent formation of renal stones, being 54% females. The laboratory investigation consisted of at least two samples of blood and 24-hour urine to assess calcium, uric acid, citrate and creatinine levels, qualitative cystinuria, urinary pH following fasting and 12-hour water restriction, urine culture, serum creatinine and parathyroid hormone. Results: The most frequent alterations were hypercalciuria (40.9%), urinary tract infection (23.2%), hypocitraturia (22.4%), low urinary volume (20.5%) and hyperuricosuria (16%). Conclusion: The most frequent metabolic alterations in females were hypocitraturia, urinary tract infection, low urinary volume and hyperuricosuria.

RESUMO Objetivo: Avaliar a prevalência dos distúrbios metabólicos associados à nefrolitíase em uma população feminina. Métodos: Foi realizado um estudo retrospectivo em 1.737 pacientes com evidência de formação recente de cálculos renais, sendo 54% do sexo feminino. A avaliação laboratorial constou de duas ou mais amostras de sangue e urina de 24 horas com dosagens de cálcio, ácido úrico, citrato e creatinina cistinúria qualitativa, pH urinário em jejum e restrição hídrica de 12 horas, urocultura, creatinina e paratormônio séricos. Resultados: As alterações mais encontradas foram hipercalciúria (40,9%), infecção do trato urinário (23,2%), hipocitratúria (22,4%), baixo volume urinário (20,5%) e hiperuricosúria (16%). Conclusão: As alterações metabólicas mais frequentes na população feminina foram hipocitratúria, infecção do trato urinário, baixo volume urinário e hiperuricosúria.

Are patients with lichen planus really prone to urolithiasis? Lichen planus and urolithiasis

ABSTRACT Purpose to investigate whether patients with lichen planus (LP) are really prone to urolithiasis or not. Patients and Methods We performed a prospective analysis of 40 patients diagnosed with lichen planus (LP) (group I), and 40 volunteers did not have LP before (group II). Participants were all checked for urolithiasis by radiological investigations. Blood samples were analyzed for biochemistry parameters including calcium and uric acid. 24-h urine samples were analyzed to investigate oxalate, citrate calcium, uric acid, magnesium, sodium and creatinine. Results Men/women ratio and mean age were similar between group I and II (p>0.05). A presence or history of urolithiasis was detected in 8 (20%) and 2 (%5) patients in group I and II, respectively (p<0.05). Hypocitraturia was the most common anomaly with 35% (n:14) in group I. The rate of hypocitraturia in group II was 12.5% (n:5) and the difference was statistically significantly different (p=0.036). In group I, hyperuricosuria and hyperoxaluria followed with rates of 27.5% (n:11) and 25% (n:10), respectively. The rate of hyperuricosuria and hyperoxaluria were both 5% (n:2) in group II and the differences were significant (p<0.05). Hyperuricemia was another important finding in the patients with LP. It was detected in 13 (32.5%) patients in group I and in 1 (2.5%) participant in group II (p=0.001). Conclusion According to our results, metabolic disorders of urolithiasis were highly detected in the patients with LP. However, similar to the etiology of LP, the exact reasons for these metabolic abnormalities in LP remain a mystery.

Perfil de riesgo litogénico en pacientes con urolitiasis en Paraguay / Lithogenic risk in patients from Paraguay with urolithiasis

The lithogenic risk profile is a graphical representation of metabolic factors and urinary saturation involved in the stone formation with their respective critical values. Aim: To determine the lithogenic risk profile in patients with urolithiasis. Material and Methods: Personal data such as anthropometric, history of diseases and family history of urolithiasis were recorded. Different compounds acting as promoters or inhibitors of crystallization were measured in serum and urine samples, and the data obtained were used to calculate urinary saturation using Equil software. Results: We included 30 men and 43 women with a median age of 45 (34-54) years. Overweight and family history of urolithiasis was reported in 63 and 32% respectively. Crystallization risk was detected in 74% of participants. The most common urinary abnormalities were hypocitraturia in 48% and hypercalciuria in 40%. Conclusions: The lithogenic profile revealed urinary saturation compatible with crystallization risk in 74% of the studied patients.

Use of the probability of stone formation (PSF) score to assess stone forming risk and treatment response in a cohort of Brazilian stone formers

Introduction The aim was to confirm that PSF (probability of stone formation) changed appropriately following medical therapy on recurrent stone formers. Materials and Methods Data were collected on 26 Brazilian stone-formers. A baseline 24-hour urine collection was performed prior to treatment. Details of the medical treatment initiated for stone-disease were recorded. A PSF calculation was performed on the 24 hour urine sample using the 7 urinary parameters required: voided volume, oxalate, calcium, urate, pH, citrate and magnesium. A repeat 24-hour urine sample was performed for PSF calculation after treatment. Comparison was made between the PSF scores before and during treatment. Results At baseline, 20 of the 26 patients (77%) had a high PSF score (> 0.5). Of the 26 patients, 17 (65%) showed an overall reduction in their PSF profiles with a medical treatment regimen. Eleven patients (42%) changed from a high risk (PSF > 0.5) to a low risk (PSF < 0.5) and 6 patients reduced their risk score but did not change risk category. Six (23%) patients remained in a high risk category (> 0.5) during both assessments. Conclusions The PSF score reduced following medical treatment in the majority of patients in this cohort. .

Influence of clinical therapy and nutritional counseling on the recurrence of urolithiasis

PURPOSE: To evaluate the influence of combined clinical therapy and nutritional guidance on the recurrence of urolithiasis. METHODS: From our registry of patients with recurrent urolithiasis we selected 57 who had at least 5-years of follow-up. We collected 24h urine samples in order to analyze Ca, Na, uric acid, citrate, oxalate, and Mg concentrations and to assess urine volume. Patients filled out a clinical questionnaire before treatment, and abdominal radiographs and/or ultrasound were performed both before treatment and during the follow-up period. During follow-up, specific and individualized dietary advice was given based on the individual's metabolic disorders. Patients also received specific pharmacological treatment for their metabolic alterations. Outcome measures were metabolites in urine and the urolith recurrence rate. Pre- and post- intervention values were compared using tests as appropriate. RESULTS: Fifty six of the patients were male and the majority of patients were overweight. The mean BMI was 27 kg/m2. Urinary excretion of calcium, uric acid and sodium decreased significantly over the five year follow-up period. The number of uroliths that formed during the 5-year follow-up also decreased significantly compared to pre-treatment values. CONCLUSION: Individualized dietary advice combined with pharmacological treatment significantly reduces long-term urolithiasis recurrence. .

Nephrocalcinosis induced by hyperoxaluria in rats

PURPOSE: To investigate nephrocalcinosis due to hyperoxaluria induced by two different inducing agents in rats. METHODS: Forty Sprague-Dawley male rats were randomly distributed into four groups: Group1 (Clinical control, n = 10); Group 2 (0.5% Ethylene Glycol + Vitamin D3, n = 10); Group 3 (1.25% Ethylene Glycol, n = 10); and Group 4 (5%Hydroxy L-proline, n = 10). Five animals from each group were euthanized after one week of follow-up (M1 Moment) and the remaining, after four weeks (M2 Moment). All animals underwent 24h urine dosages of calcium, oxalate, uric acid, citrate and serum creatinine. Histology and histomorphometric analyses were performed using Image J program in the hematoxylin-eosin stains. Calcium deposits in the renal parenchyma were quantified by PIXE technique (Proton Induced X-Ray Emission). RESULTS: 24h urinary parameters did not show any significant variations after 28 days of experiment except by hyperoxaluria that was significantly higher in Group 3. Histomorphometric analyses showed a significantly higher nephrocalcinosis in Group 2 (p<0.01). The calcium deposits in the renal parenchyma were 10 and 100 times higher in Group 2 in comparison to other groups in the M1 and M2 moments, respectively. CONCLUSION: The Group 2 (vitamin D3+Ethylene Glycol 0.5%) was the best model to induce nephrocalcinosis in rats after 28 days.

Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy

OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05 percent) of Group I and 15 of 37 patients (40.5 percent) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69 percent) and 14 of 37 (37.83 percent) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3 percent of the treated group and 57.7 percent of the control group were still stone free. Of the residual stone group, 30.8 percent and 9.1 percent of treated and control group were stone-free, respectively. The increased stone size found in 7.7 percent and 54.5 percent of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.

To study the efficacy of losartan on urinary uric acid excretion in thiazide induced hyperuricemic and hypertensive patients

The precise relationship of Hyperuricemia found in hypertensive patients is still obscure; this study is a urinary uric acid lowering intervention with Losartan in hypertensive patients induced by Thiazide diuretics. A number of pharmacological agents like loop diuretics, similarly low doses of aspirin [<3g daily] aggravate Hyperuricemia. The effect of Losartan on urinary uric acid excretion In Hypertensive patients with Thiazide induced Hyperuricemia were investigated in the Department of pharmacology and therapeutics, Basic Medical Sciences Institute Jinnah Postgraduate Medical Centre Karachi. It was randomized, open label, prospective, comparative study. Total 60 hypertensive Hyperuricemic patients were enrolled one by one in this study, selected from medical OPD and wards of Jinnah Postgraduate Medical Centre, Karachi. Patients were divided in three groups. Group-1 patients were treated with Thiazide 50 mg/day, Group-2 with Losartan + Thiazide 50 mg/day, and Group-3 with Losartan 50 mg/day. The effect on urinary uric acid level was measured, after every fortnightly. Treatment with Thiazide + Losartan group and Losartan group showed significantly increase in urinary uric acid excretion. Whereas, Thiazide group decrease in urinary uric acid level. In contrast to Thiazide and Losartan alone Thiazide + Losartan led to a greater increased in urinary uric acid excretion. The average percentage increase in urinary uric acid excretion in Thiazide + Losartan group was -13.27% and the average percentage increased in urinary uric acid excretion was 6.7% in Losartan group. Thus it can be concluded from the present study that urinary uric acid excretion was more increased in combination therapies. Ultimately Losartan decrease serum uric acid level and uricosuric effect of Losartan might be particularly useful in Hyperuricemic patients those on Thiazide diuretic [for hypertension and heart failure]

Urinary lithiasis and idiopathic hypercalciuria: the importance of dietary intake evaluation

PUSPOSE: To evaluate food intake of patients with urinary lithiasis and idiopathic hypercalciuria (IH). MATERIALS AND METHODS: Between August 2007 and June 2008, 105 patients with lithiasis were distributed into 2 groups: Group 1 (n = 55) - patients with IH (urinary calcium excretion > 250 mg in women and 300 mg in men with normal serum calcium); Group 2 (n = 50) - normocalciuria (NC) patients . Inclusion criteria were: age over 18, normal renal function (creatinine clearance = 60 mL/min), absent proteinuria and negative urinary culture. Pregnant women, patients with some intestinal pathology, chronic diarrhea or using corticoids were excluded. The protocol of metabolic investigation was based on non-consecutive collection of two 24-hour samples for dosages of: calcium, sodium, uric acid, citrate, oxalate, magnesium and urinary volume. Food intake was evaluated through the quantitative method of Dietary Register of three days. RESULTS: Urinary excretion of calcium (433.33 ± 141.92 vs. 188.93 ± 53.09), sodium (280.08 ± 100.94 vs. 200.44.93 ± 65.81), uric acid (880.63 ± 281.50 vs. 646.74 ± 182.76) and magnesium (88.78 ± 37.53 vs. 64.34 ± 31.84) was significantly higher in the IH group in comparison to the NC group (p < 0.05). As regards the nutritional composition of food intake of IH and NC groups, there was no statistical significant difference in any nutrient evaluated. CONCLUSION: In our study, no difference was observed in the food intake of patients with urinary lithiasis and IH or NC.

Urinary uric acid in preterm neonates.

Objective. Study of uric acid level in spot urine of normal preterm AGA (appropriate for gestational age) babies in day one of their life. Methods. Spot urine samples were collected from 45 normal preterm neonates within 24 hours of their birth for estimation of uric acid. Results. The mean uric acid level was 36.50 ± 5.99 mg/dl in normal preterm neonates as compared to 18.40 ± 0.45 mg/dl in normal term babies (documented in another study) (p < 0.001). Also a significant negative linear correlation between body weight and urinary uric acid level was found { r (correlation coefficient) = – 0.970, P (probability) < 0.001}. Conclusion. Higher mean uric acid level was found in spot urine samples of preterm normal neonates than that of normal term babies on day one. Further, urinary uric acid levels were found inversely proportional to the body weight or to the gestational age (as they are AGA) of the babies.

Clinical features and risk factors of pediatric urolithiasis

Urolithiasis in children although occurring less often than adults, causes considerable morbidity. The main aim of this study is to evaluate clinical features and risk factors of pediatric urolithiasis. All children with documented urolithiasis who were referred to department of pediatric nephrology between 1999 and 2005, were evaluated from the point of demographic features, family history, clinical symptoms, imaging results and laboratory findings. We investigated 184 patients [100 females and 84 males] with urolithiasis between 2 months and 14 years of age [mean age 3.66 +/- 3.49 years]. The stones' diameter was 3-27 mm [mean 8.20 +/- 5.36]. In 85.8% of cases the stone was located only in kidneys and in 3.3% only in bladder. The most common causes of presentation were urinary tract infection [UTI], restlessness and gross hematuria. Positive family history was detected in 41%, UTI in 40.8%, anatomic abnormality in 13% and sterile pyuria in 18.5% of patients. Metabolic evaluation, which was carried out in 162 patients, revealed that 104 [64%] of them had a metabolic risk factor including normocalcemic hypercalciuria [42%], Hyperuricosuria [10.5%], Cystinuria [7.4%], and Hyperoxaluria [4.3%]. All children with urolithiasis should be completely evaluated, as most of them have an anatomic, infectious or metabolic risk factor

Serum uric acid concentration and urinary excretion of uric acid in Sudanese patients with gout

To assess the relationship between serum uric acid concentration and urinary excretion of uric acid in patients with gout. Fifty three Sudanese patients with gout were included in this study; thirty three of them were gouty subjects not under treatment, twenty subjects were under treatment. Twenty normal subjects were used as control. The biochemical parameters included in this study were: serum uric acid, urine uric acid. Urine volume, pH, specific gravity, and urine crystals were also determined. Serum uric acid concentration in gouty subjects not under treatment was significantly higher [p<0.01] as compared to control group. While serum uric acid concentration in gouty subjects under treatment was not significantly higher than the control group, the difference between means was statistically significant between gouty subjects not under treatment and control group. No significant differences were found for urine uric acid excretion. There was a weak positive correlation between serum uric acid concentration and urinary excretion of uric acid in gouty groups; however control group gave a weak negative sign. The risk factors, which were considered, were obesity [over weight], ethnic origin, and age. The difference between means for body weight and height was significantly higher [P<0.05] in gouty subjects compared with control group, and the difference between means for urine volume, urine specific gravity, and urine crystalls showed no significant effect on the three groups, while urine pH showed significant mean difference between these groups. The determination of serum uric acid is of good diagnostic value, whereas estimation of urine uric acid is of little diagnostic value. Urine crystals can be used only for screening for the investigation of urine uric acid crystals

Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs.

Disposition of uric acid upon administration of ofloxacin (O) alone and in combination with other anti-tuberculosis drugs, rifampicin (R), isoniazid (H) and pyrazinamide (Z) was studied. Twelve male healthy volunteers were investigated on four different occasions with the four drugs alone or in combinations. A partially balanced incomplete block design was adopted and the subjects were randomly allocated to each group. Uric acid concentration in urine samples excreted over 0-8 hr, were determined after coding the samples. There was significant decrease in the group receiving Z when compared to other groups. Though there was a decrease in uric acid excretion in the group receiving O, it was not statistically significant. Rifampicin and H seem to increase the uric acid excretion. The incidence of arthralgia was mainly due to Z and not due to either O or other drugs in the treatment of pulmonary tuberculosis.

Dietary risk factors and impact of drinking water on urolithiasis at Quetta

This study was conducted at PCSIR Laboratories, Lahore and Department of Pathology, Bolan Medical College, Quetta from January 1991 to December 1991. Impact of drinking water i.e. its hardness and calcium contents on urolithiasis was studied. Thirty adult patients, both males and females of upper urinary tract stones [Group-1] compared with those of 17 age matched control [Group-11] from Quetta city were included in this study. Mean age of Group-1 was 30.63 and +/- SD 3.58 and of Group-11 was 28.62 +/- SD 2.60. Mean serum calcium level of Goup-1 was 9.56 mg/100ml and +/- SD 0.7 and of Group-11 was 8.8mg/100ml +/- SD 1.30, which was significant [p<0.05]. Mean 24 hours urinary excretion of calcium in Group-1 was 287.79 [ +/- SD 181.29] and in Group-11 187mg [ +/- SD 88.91], which is significant. Mean serum uric acid was 5.37mg/dl [ +/- SD 1.66] in Group-1 and 5.40mg/dl [ +/- SD 1.52] in Group-11 which is non significant. Mean 24 hour urinary excretion of uric acid in stone patients was 424.31mg +/- SD 142.16 and in normal subjects it was 314.29mg +/- SD 173.49 [significant at p<0.05]. Stone formers had a mean 24-hour urinary out put of 1336.7 ml +/- SD 773.83, while non-stone formers had a mean out put of 1129.41ml +/- SD 512.36, which is not significant. Mean pH of freshly voided urine of Group-1 had 6.24 +/- SD 0.78, while in Group-11 had 6.12 +/- SD 0.38 and was not significant. Economic status and family history of both group was also analysed. Mean +/- SE Comparison of various variables of drinking water of Quetta were also analysed